SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
1.880
-0.220 (-10.48%)
At close: Mar 28, 2025, 4:00 PM
1.984
+0.104 (5.54%)
Pre-market: Mar 31, 2025, 6:24 AM EDT
Company Description
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control.
It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.
Country | United States |
Founded | 2004 |
IPO Date | Dec 8, 2016 |
Industry | Specialty Chemicals |
Sector | Materials |
Employees | 23 |
CEO | Joel Fruendt |
Contact Details
Address: 23460 North 19th Avenue, Suite 110 Phoenix, Arizona 85027 United States | |
Phone | 928 779 4143 |
Website | senestech.com |
Stock Details
Ticker Symbol | SNES |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001680378 |
CUSIP Number | 81720R208 |
ISIN Number | US81720R5054 |
Employer ID | 20-2079805 |
SIC Code | 2870 |
Key Executives
Name | Position |
---|---|
Joel L. Fruendt | Chief Executive Officer, President and Director |
Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
Robert Blum | Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 25, 2025 | D | Notice of Exempt Offering of Securities |
Mar 13, 2025 | 10-K | Annual Report |
Mar 12, 2025 | 8-K | Current Report |
Mar 11, 2025 | 8-K | Current Report |
Feb 14, 2025 | SCHEDULE 13G/A | Filing |
Feb 12, 2025 | SCHEDULE 13G/A | Filing |
Jan 10, 2025 | 8-K | Current Report |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | 10-Q | Quarterly Report |